Metraipolis › archive › dc_ad363567ae32

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell… — Europe PMC PMID:41122636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41122636
DOI
10.3389/fonc.2025.1645509
License (as archived)
solo-consultazione
Archived
2026-11-09T13:40:11.859Z
SHA-256 of the archived text
2409baa87eb708bdbca6dbd73c6769643dffdf61891a64c490f57173c4ca2c16
Stable URL of this page
https://metraipolis.com/documento/dc_ad363567ae32

How to cite

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell… — Europe PMC PMID:41122636 — Europe PMC (en), https://europepmc.org/article/MED/41122636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad363567ae32 (Metraipolis archive dc_ad363567ae32, sha256 2409baa87eb708bdbca6dbd73c6769643dffdf61891a64c490f57173c4ca2c16)
BibTeX
@misc{dcad363567ae32,
  title = {Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell… — Europe PMC PMID:41122636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41122636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad363567ae32; sha256 2409baa87eb708bdbca6dbd73c6769643dffdf61891a64c490f57173c4ca2c16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122636. Agents can read the archived copy with the MCP tool read_document.